Navigation Links
Genmab Announces Upcoming Ofatumumab Studies
Date:8/25/2008

Front Line CLL, NHL and CLL Retreatment and Japanese Development Studies

Planned

COPENHAGEN, Denmark, August 25 /PRNewswire-FirstCall/ -- Genmab has announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Genmab A/S (OMX: GEN) announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.

"Genmab and GSK have worked diligently to expand the ofatumumab development program to maximize the value of the antibody for patients and shareholders since our collaboration began," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab."The new studies we are initiating this year will examine the potential of ofatumumab in Japan as well as a number of new treatment settings - retreatment, maintenance and front line with chlorambucil."

Phase III CLL front line chlorambucil combination This open-label, parallel-arm study will include 444 patients with previously untreated CLL.Patients in the study will be randomized to receive ofatumumab in combination with chlorambucil or chlorambucil alone.Patients receiving ofatumumab in combination with chlorambucil will receive one infusion of ofatumumab at 300 mg, one infusion at 1000 mg a week later, followed by up to 11 monthly infusions at 1000 mg.Patients will be evaluated for disease status one month following last treatment then every 3 months for 5 years.

The primary objective of the study is to evaluate the progression free survival of ofatumumab in combination with chlorambucil therapy versus chlorambucil therapy alone for the treatment of front line CLL.

Phase II CLL ofatumumab retreatment and maintenance treatment study This study will examine the retreatment and maintenance treatment of refractory CLL patients who participated in the ongoing Phase III CLL study and had disease progression following
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
2. Bionomics Achieves US$1 Million Milestone Payment from Genmab
3. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
4. Genmab Announces Updates on Phase III Cancer Studies
5. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
6. Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
7. Genmab Reaches Milestone in Ofatumumab Collaboration
8. Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
9. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... FRANCISCO , July 1, 2015 ... market) is expected to reach USD 49,119.2 million by ... Research, Inc. Monitoring services is expected to remain the ... of USD 1,227.5 million in 2012, and an estimated ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
(Date:6/30/2015)... , June 30, 2015 Velos, Inc., the ... continues to grow and add customers who receive Clinical ... the 62 CTSAs awarded by the National Institutes of ... management. This is among the largest such market shares ... in the CTSA community keeps growing as a result ...
Breaking Medicine Technology:mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Velos continues adding CTSA customers - 40% now use Velos products 2
... 2011 The Mobile Dog Heart Health Tour is heading ... health examinations at Dreher Dog Park. From 1 to 5 ... on-site heart screenings in a soundproof medical unit, as well ... (Photo:   http://photos.prnewswire.com/prnh/20110127/CG37759 ) Since early 2009, veterinarians ...
... Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUSD) ("Lotus" or ... of medicine and drugs in the People,s Republic of ... investor interest, the Company has obtained land price guidance ... wishes to provide additional details regarding its 2008 purchase ...
Cached Medicine Technology:Vets to Provide Free Dog Heart Checks in West Palm Beach 2Vets to Provide Free Dog Heart Checks in West Palm Beach 3Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government 2
(Date:7/1/2015)... Salt Lake City, UT (PRWEB) , ... July ... ... opportunity to compare the different philosophies and approaches to case management, placement, sober ... also have different training and approaches to working with and transporting clients with ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... Georgia and the Florida Panhandle, the regional southeast Alabama community health system ... and clinical communications workflow solution provider. TelmedIQ, a burgeoning leader in secure ...
(Date:7/1/2015)... FL (PRWEB) , ... July 01, 2015 , ... Nutritional ... range of nutritional and beauty products, recently attended the 2015 ECRM Diet, Vitamin & ... connections in the retail industry. The ECRM trade show allows companies the ...
(Date:7/1/2015)... ... 2015 , ... Foot and Ankle Specialists of the Mid-Atlantic, LLC (FASMA) ... annual Howard County Family Wellness Day event at Centennial Park on June 7, 2015. ... for children, free workout demonstrations, and more. Drs. Becker and Friske educated attendees ...
(Date:7/1/2015)... ... 2015 , ... Recent research has revealed that most adults lack confidence in ... to professionals. Starting the last Monday of June, Whiter Image Dental will ... discount on the customer’s first popular In-Office 2 Patient Kit. , ...
Breaking Medicine News(10 mins):Health News:All Kinds of Therapy – Announces New Partnership Feature, Therapeutic Experts 2Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2Health News:NPI Meets With Top Retail Figures at ECRM Conference 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 3Health News:Whiter Image Dental Offers New Customers Half-Off Teeth Whitening Kit 2
... study describes a new agent, called "Zorro-LNA," which has ... In the study, researchers from the Karolinska// Institute in ... with both strands of a gene’s DNA simultaneously, effectively ... clinical implications for virtually every human condition caused by ...
... that patients suffering dementia lead a troubled existence due to ... lives. An// estimated 700,000 such patients live in The United ... is the worst that can happen to such patients; lack ... can plunge them into deeper despair. ,The study, ...
... ill young children dying in intensive care after being admitted to ... end of the 1990s,// reveals a study in the Journal of ... one large children’s hospital, to find out where children had died, ... spanned seven years from 1997 to 2004 and included all age ...
... is giving to a serious health crisis in Canada, many fear.// ... ago, about five million Canadians, or 17 per cent of the ... doctorless people, nearly two million of them, or 38 per cent, ... but have failed. ,Not having a family physician makes ...
... Loss of memory in people suffering from neuro-degenerative diseases, ... drugs that trigger the natural "rewiring" of brain// cells, ... in Cambridge, Massachusetts, and colleagues used mice that were ... an antibiotic. Previous studies have suggested that p25 is ...
... representatives from 150 nations gathered in Bangkok Monday for ... carbon emissions to slow global warming. ,"The ... of Thailand's ministry of natural resources and environment, in ... Change (IPCC). ,"Global warming has increasingly ...
Cached Medicine News:Health News:New Agent to Fight Genetic Disorders Found 2Health News:Dementia – Worse With a Dull Life. Keep Busy, and Active to Improve Memory, Study Recommend 2Health News:Significant Rise in Proportion of Chronically Ill Children Dying in Intensive Care 2Health News:Canadians Despair for Family Doctors 2
... Level 1 enables hospitals ... patient monitors to a ... Our temperature monitoring disposale ... are superior in their ...
... The pause of a heartbeat. The bodys ... rhythmic breathing. These vital signs are yours ... DeRoyals line of Temperature Monitoring products helps ... information needed to provide the most comfortable ...
... a heartbeat. The bodys warmth beneath drapes. ... vital signs are yours to guard, measure, ... Temperature Monitoring products helps you do your ... provide the most comfortable and precise management ...
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
Medicine Products: